F-6 POS

POST EFFECTIVE AMENDMENT NO. 1 TO THE FORM F-6

Company: Can-Fite BioPharma Ltd.
Filed: August 21, 2013
Accession Number: 0001019155-13-000427

View Document ↗ View on SEC.gov ↗